Join our team

Hyrax Biosciences is extending their co-marketing agreement with Roche to include integrated sample preparation workflows for HIV, TB and respiratory virus panels. With Hyrax Biosciences' streamlined analysis and Roche's KAPA HyperCap and KAPA HyperPETE workflows for Next Generation Sequencing (NGS) Sample Preparation, users can expect faster turn-around times, sequencing efficiency, and panel-specific consolidated reporting.

On Wednesday (30 March 2022), the WHO released an updated, and the third version, of their Strategic Preparedness, Readiness and Response Plan for COVID-19. During his opening remarks at the press conference, WHO Director General, Dr Tedros Adhanom Ghebreyesus, emphasised the importance of equitable vaccination and continued surveillance – not only in response to COVID-19, but also for future epidemics.